Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2012
11/01/2012WO2012099985A3 Main stream gas analyzing device
11/01/2012WO2012094643A3 Esophageal cytokine expression profiles in eosinophilic esophagitis
11/01/2012WO2012094550A3 Assays and methods of treatment relating to vitamin d insufficiency
11/01/2012WO2012094502A3 Sensor array mounted on flexible carrier
11/01/2012WO2012087160A3 Anti-inflammatory proteins and methods of preparation and use thereof
11/01/2012WO2012085574A3 Detection of acute myeloid leukaemia
11/01/2012WO2012085557A3 Methods and biomarkers for differentially diagnosing psychotic disorders
11/01/2012WO2012080929A3 Use of ide as a biomarker for a scalp condition
11/01/2012WO2012078793A3 Methods and compositions related to tazarotene-induced gene 1 (tig1)
11/01/2012WO2012078502A3 Biomarker test for acute coronary syndrome
11/01/2012WO2012075340A3 Anti-ngf compositions and use thereof
11/01/2012WO2012052994A3 Markers of primary graft dysfunction
11/01/2012WO2012050365A3 Biomarker for diagnosing glioblastoma or predicting prognosis of glioblastoma patients, and use thereof
11/01/2012WO2012048224A3 Sampling system based on microconduit lab on chip
11/01/2012WO2012025077A4 Method for the fast serological diagnosis of a salmonella subtype
11/01/2012WO2012012803A3 Methods for detection of rare subpopulations of cells and highly purified compositions of cells
11/01/2012WO2011116401A9 Arsenical fluorescent agents and assays
11/01/2012US20120278909 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
11/01/2012US20120277998 System And Methods For Characterizing A Biological Condition Or Agent Using Selected Gene Expression Profiles
11/01/2012US20120277553 Spectrophotometric measurement in color-based biochemical and immunological assays
11/01/2012US20120277326 Biomarkers of cancer
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277225 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277212 Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors
11/01/2012US20120277203 Androstenediol as an indicator for assessing estrogenicity
11/01/2012US20120277116 Disease diagnosis according to saccharide binding
11/01/2012US20120277111 MicroRNA Mediated Neuronal Cell Induction
11/01/2012US20120277110 Parp and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer
11/01/2012US20120277109 Proximity-mediated assays for detecting oncogenic fusion proteins
11/01/2012US20120276648 Electrostatically stabilized metal sulfide nanoparticles for colorimetric measurement of hydrogen sulfide
11/01/2012US20120276641 Microfluidic device providing degassing driven fluid flow
11/01/2012US20120276574 Microfluidic mixer
11/01/2012US20120276571 Method of analyzing formation and phase transition characteristic of amorphous calcium carbonate
11/01/2012US20120276562 5.9 kDa PEPTIDE IMMUNOASSAY METHOD
11/01/2012US20120276561 Marker protein for type-2 diabetes
11/01/2012US20120276560 Biomarkers for assessing sialic acid deficiencies
11/01/2012US20120276559 Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
11/01/2012US20120276558 Kits for multiparametric phospho analysis
11/01/2012US20120276557 Method for the quantitative and qualitative characterization of antigen-specific t cells recognizing a specific antigen
11/01/2012US20120276556 Ligating BDCA-2 Protein for the Purpose of Isolating or Modulating Dendritic Cells
11/01/2012US20120276553 Mesenchymal precursor cell
11/01/2012US20120276552 Serum spla2-iia as diagnosis marker for prostate and lung cancer
11/01/2012US20120276551 Methods predicting risk of an adverse clinical outcome
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276545 Method for using division arrested cells in screening assays
11/01/2012US20120276544 Microfabricated Crossflow Devices and Methods
11/01/2012US20120276543 Microfabricated Crossflow Devices and Methods
11/01/2012US20120276529 Mutated sumo isoforms and uses thereof
11/01/2012US20120276528 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/01/2012US20120276525 Method and system for preventing virus-related obesity and obesity related diseases
11/01/2012US20120276523 Liquid drop diagnostic assays
11/01/2012US20120276521 ORAL FLUID RAPID ASSAY FOR HEPATITIS C VIRUS (HCV) ANTIBODIES USING NON-ANTIBODY LABELING OF lgA MOLECULES RECOGNIZING HCV PEPTIDE EPITOPES
11/01/2012US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012US20120276145 Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
11/01/2012US20120276135 Methods for improving the design, bioavailability, and efficacy of random sequence polymer compositions via serum protein-based detection of random sequence polymer compositions
11/01/2012US20120276131 Anti-trypanosomiasis vaccines and diagnostics
11/01/2012US20120276130 Diagnostic and therapeutic methods for rheumatic heart disease based upon group a streptococcus markers
11/01/2012US20120276129 Neisserial antigenic peptides
11/01/2012US20120276122 Methods for diagnosis and treatment of cellular proliferative disorders
11/01/2012US20120276120 T-Cell Stimulating Protein B and Methods of Use
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276114 Ifn-gamma inhibitors in the treatment of motoneuron diseases
11/01/2012US20120276113 Methods of treating and preventing colitis involving il-13 and nk-t cells
11/01/2012US20120276107 Methods and Compositions for Mycoplasma Pneumoniae Exotoxins
11/01/2012US20120276102 Methods of treatment utiliziing binding proteins of the interleukin-21 receptor
11/01/2012US20120276091 Human Recombinant Monoclonal Antibody That Specifically Binds to VCAM-1 and Inhibits Adhesion and Transmigration Between Leukocytes and Endothelial Cells
11/01/2012US20120276090 Gene recombinant antibody and antibody fragment thereof
11/01/2012US20120276079 Method of producing recombinant vitamin k dependent proteins
11/01/2012US20120276067 Assay for the Prediction of Therapeutic Effectiveness of Mesenchymal Stromal Cells, and Methods of Using Same
11/01/2012US20120276065 Dendritic Cell Populations that are Enriched for Cells that Bear the BDCA-1 Antigen
11/01/2012US20120276060 Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with clostridium difficile disease
11/01/2012US20120276059 Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120276014 Measurement of body fluid volumes
11/01/2012US20120276009 Pharmaceutical composition
11/01/2012US20120276007 Imaging agents and methods of imaging naaladase or psma
11/01/2012US20120276004 Human myeloid derived suppressor cell cancer markers
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012US20120275970 Centrifuge
11/01/2012US20120275957 Test-sensor cartridge
11/01/2012US20120275956 Sample analyzer and storage medium
11/01/2012US20120273671 Method and kit for determining metabolites on dried blood spot samples
11/01/2012US20120272754 Testing device for testing rivets
11/01/2012US20120272743 Method and Apparatus for Laser-Based Non-Contact Three-Dimensional Borehole Stress Measurement and Pristine Stress Estimation
11/01/2012US20120272713 Breath actuation of electronic and non-electronic devices for preventing unauthorized access
11/01/2012US20120272709 Biological component-measuring device and method for calibrating the same
11/01/2012CA2834676A1 Methods of predicting the development of complement-mediated disease
11/01/2012CA2834535A1 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
11/01/2012CA2834400A1 Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
11/01/2012CA2834383A1 Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
11/01/2012CA2834243A1 Anti-human receptor-type protein tyrosine phosphatase .sigma. antibody
11/01/2012CA2834056A1 Ocular detection of amyloid proteins
11/01/2012CA2833806A1 Method for treatment of macular degeneration by modulating p2y12 or p2x7 receptors
11/01/2012CA2833390A1 Hsp90 combination therapy
11/01/2012CA2833214A1 Automatic gemstone orientation
11/01/2012CA2833118A1 Method for determining prognosis of renal failure
11/01/2012CA2827521A1 Formation resistivity imager with reduced leakage to mandrel
11/01/2012CA2818940A1 Method and apparatus for determination of system parameters for reducing crude unit corrosion
10/2012
10/31/2012EP2518512A1 Method for indicating a renal disease in a patient by determining at least one protein in isolated HDL
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 3937